These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17766836)

  • 1. Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting.
    Falciani C; Fabbrini M; Pini A; Lozzi L; Lelli B; Pileri S; Brunetti J; Bindi S; Scali S; Bracci L
    Mol Cancer Ther; 2007 Sep; 6(9):2441-8. PubMed ID: 17766836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
    J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents.
    Falciani C; Brunetti J; Pagliuca C; Menichetti S; Vitellozzi L; Lelli B; Pini A; Bracci L
    ChemMedChem; 2010 Apr; 5(4):567-74. PubMed ID: 20222099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting.
    Mascarin A; Valverde IE; Vomstein S; Mindt TL
    Bioconjug Chem; 2015 Oct; 26(10):2143-52. PubMed ID: 26347939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F- and (68)Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1.
    Maschauer S; Einsiedel J; Hübner H; Gmeiner P; Prante O
    J Med Chem; 2016 Jul; 59(13):6480-92. PubMed ID: 27336295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors.
    García-Garayoa E; Allemann-Tannahill L; Bläuenstein P; Willmann M; Carrel-Rémy N; Tourwé D; Iterbeke K; Conrath P; Schubiger PA
    Nucl Med Biol; 2001 Jan; 28(1):75-84. PubMed ID: 11182567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modular branched neurotensin peptides for tumor target tracing and receptor-mediated therapy: a proof-of-concept.
    Falciani C; Lelli B; Brunetti J; Pileri S; Cappelli A; Pini A; Pagliuca C; Ravenni N; Bencini L; Menichetti S; Moretti R; De Prizio M; Scatizzi M; Bracci L
    Curr Cancer Drug Targets; 2010 Nov; 10(7):695-704. PubMed ID: 20578987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel multimeric neurotensin(8-13) analogs.
    Hultsch C; Pawelke B; Bergmann R; Wuest F
    Bioorg Med Chem; 2006 Sep; 14(17):5913-20. PubMed ID: 16735124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model.
    Hillairet De Boisferon M; Raguin O; Thiercelin C; Dussaillant M; Rostène W; Barbet J; Pélegrin A; Gruaz-Guyon A
    Bioconjug Chem; 2002; 13(3):654-62. PubMed ID: 12009958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry.
    Lin W; Aluicio-Sarduy E; Houson HA; Barnhart TE; Tekin V; Jeffery JJ; Weichmann AM; Barrett KE; Lapi SE; Engle JW
    Nucl Med Biol; 2023; 118-119():108329. PubMed ID: 36805869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.
    García-Garayoa E; Bläuenstein P; Bruehlmeier M; Blanc A; Iterbeke K; Conrath P; Tourwé D; Schubiger PA
    J Nucl Med; 2002 Mar; 43(3):374-83. PubMed ID: 11884498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
    Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
    Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides.
    Falciani C; Accardo A; Brunetti J; Tesauro D; Lelli B; Pini A; Bracci L; Morelli G
    ChemMedChem; 2011 Apr; 6(4):678-85. PubMed ID: 21370475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
    Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE
    J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.
    García-Garayoa E; Maes V; Bläuenstein P; Blanc A; Hohn A; Tourwé D; Schubiger PA
    Nucl Med Biol; 2006 May; 33(4):495-503. PubMed ID: 16720241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysine.
    Lundquist JT; Dix TA
    J Med Chem; 1999 Nov; 42(23):4914-8. PubMed ID: 10579853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities.
    Lundquist JT; Büllesbach EE; Dix TA
    Bioorg Med Chem Lett; 2000 Mar; 10(5):453-5. PubMed ID: 10743946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tetrabranched neurotensin(8-13) cyclam derivative: synthesis, 64Cu-labeling and biological evaluation.
    Röhrich A; Bergmann R; Kretzschmann A; Noll S; Steinbach J; Pietzsch J; Stephan H
    J Inorg Biochem; 2011 Jun; 105(6):821-32. PubMed ID: 21497581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.